ENJPY yields 2.74% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, ENJPY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENJPY + PFE for your $10,000?
en-japan inc. provides online recruitment, recruiting and staffing, employee training, and HR consulting and aptitude test services in Japan and internationally. The company operates job information sites, including en TENSHOKU for various recruitment and career change support services; en TENSHOKU WOMAN, a career-change support services for women; AMBI, a career change site designed for young people; MIDDLE NO TENSHOKU, a recruitment website; en HAKEN, a job-search site for temporary employment; en BAITO, a recruitment website for part-time and casual job information; en WOMEN WORK, a recruitment site for women professionals; and ONNA NO KYUJIN MART, a centralized recruitment site for female professionals. It also provides recruiting services, such as en AGENTS that offers professional and specialized support services; en Lighthouse, a word-of-mouth site; CAREER HACK, a career information site for professionals in web and IT industries; and SMART GYOKAI MAP, an industry research site that explains various companies and trends in specific industries. In addition, the company operates en JINJI NO MIKATA, a recruitment support services for HR professionals; en COLLEGE for employee education services; engage, a website for recruitment support tool; HR OnBoard, an employee retention risk identification tool; and 3E TEST for assessing the talent pool, as well as provides evaluation and education consulting services. The company was founded in 2000 and is based in Tokyo, Japan.
Full ENJPY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.